Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/7296| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Crvenkova, Simonida | en_US |
| dc.date.accessioned | 2020-03-16T13:26:23Z | - |
| dc.date.available | 2020-03-16T13:26:23Z | - |
| dc.date.issued | 2018-12-20 | - |
| dc.identifier.issn | 1857-9655 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/7296 | - |
| dc.description.abstract | Combined modality therapy is standard of care for patients with inoperable locally advanced non-small cell lung cancer (NSCLC), however, insufficient data exist regarding what chemoradiotherapy combination will be the gold standard. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | ID Design 2012/DOOEL Skopje | en_US |
| dc.relation.ispartof | Open Access Macedonian Journal of Medical Sciences | en_US |
| dc.title | Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated With Combination of Chemotherapy and Conformal Radiotherapy | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.3889/oamjms.2018.490 | - |
| dc.identifier.url | https://www.id-press.eu/mjms/article/download/oamjms.2018.490/2682 | - |
| dc.identifier.url | https://www.id-press.eu/mjms/article/download/oamjms.2018.490/2713 | - |
| dc.identifier.volume | 6 | - |
| dc.identifier.issue | 12 | - |
| dc.identifier.fpage | 2323 | - |
| dc.identifier.lpage | 2327 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.